Sign in

    Simona Stan

    Managing Director and Senior Equity Analyst at Wells Fargo

    Simona Stan is a Managing Director and Senior Equity Analyst at Wells Fargo Securities, specializing in the consumer and retail sectors with coverage of companies such as Walmart, Target, Kroger, and Costco. Known for her sharp analytical skills, she maintains a strong track record highlighted by a success rate above 65% and consistent top-quartile rankings on platforms like TipRanks, contributing solid returns for investors. Simona began her career in investment research in the early 2000s, with previous roles at J.P. Morgan and UBS before joining Wells Fargo in 2018. She holds FINRA Series 7 and Series 63 licenses and is recognized for her insightful industry commentary and contributions to major investor conferences.

    Simona Stan's questions to Ascendis Pharma (ASND) leadership

    Simona Stan's questions to Ascendis Pharma (ASND) leadership • Q3 2024

    Question

    Speaking for Derek Archila, Simona Stan asked about payer progress for SKYTROFA's adult indication and whether the YORVIPATH launch would require medical exceptions for access.

    Answer

    Jan Mikkelsen, President and CEO, noted that SKYTROFA's market access has improved and the strategy remains focused on its high-value position, with a net value 3x that of daily growth hormone. For YORVIPATH, he expressed high confidence in reimbursement, stating that since it is on-label, aligns with guidelines, and is the only approved product, access should be straightforward.

    Ask Fintool Equity Research AI